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SUMMARY
Streptococcus pyogenes (group A streptococcus) strains may express several distinct fibronectin-
binding proteins (FBPs) which are considered as major streptococcal adhesins. Of the FBPs,
SfbI was shown in itro to promote internalization of the bacterium into host cells and has
been implicated in persistence. In the tropical Northern Territory, where group A streptococcal
infection is common, multiple genotypes of the organism were found among isolates from
invasive disease cases and no dominant strains were observed. To determine whether any FBPs
is associated with invasive disease propensity of S. pyogenes, we have screened streptococcal
isolates from bacteraemic and necrotizing fasciitis patients and isolates from uncomplicated
infections for genetic endowment of 4 FBPs. No difference was observed in the distribution of
sfbII, fbp54 and sfbI between the blood isolates and isolates from uncomplicated infection. We
conclude that the presence of sfbI does not appear to promote invasive diseases, despite its
association with persistence. We also show a higher proportion of group A streptococcus
strains isolated from invasive disease cases possess prtFII when compared to strains isolated
from non-invasive disease cases. We suggest that S. pyogenes may recruit different FBPs for
different purposes.
INTRODUCTION
Among the Aboriginal population living in the
Northern Territory of Australia (NT), the incidence
and prevalence of streptococcal infection and strep-
tococcal diseases are high [1]. More than 100 different
molecular types of S. pyogenes strains are circulating
in the tropical region of the NT [2]. The incidence of
acute rheumatic fever in Aboriginal populations is
amongst the highest reported even though the iso-
lation rate of S. pyogenes from throat swabs is low [3].
Skin is the major reservoir for S. pyogenes in this
* Author for correspondence: Queensland Institute of Medical
Research, 300, Herston Road, Herston Qld 4006, Australia.
population. The rate of streptococcal invasive diseases
among the Aboriginal population is five times that of
the general population and acute glomerulonephritis
is endemic among the Australian Aborigines [1, 4, 5].
Interestingly, invasive S. pyogenes diseases in the
indigenous population are not due to a dominant
clone [4].
Adherence is the first step in colonization of hosts
by bacterial pathogens, and bacterial adhesins may be
useful vaccine antigens [6]. In S. pyogenes, adherence
could be mediated by different surface exposed
proteins, which include among others, fibronectin
binding proteins (FBPs) [7–12]. Four FBPs (SfbI, OF,
PrtFII and Fbp54) have been extensively studied.
392 A. DelVecchio and others
Among these, SfbI promotes intracellular invasion of
group A streptococcus [13]. SfbI coated latex beads
not only adhere to HEp2 cells but are also internalized
into these cells, suggesting that SfbI by itself is
sufficient for internalization of the bacteria into host
cells. In some group A streptococcal strains, OF
(opacity factor), a FBP responsible for causing
opalescence of serum, was shown to be a major
adhesin [8, 14, 15]. FBP54 was shown to be an adhesin
for buccal epithelial cells but not for HEp2 cells [7].
Not all group A streptococcal strains have genetic
endowment to express all the four FBPs. The
differences in the repertoire of FBPs may reflect the
propensity of the strains to colonize different tissues
and thereby cause different patterns of diseases. To
this end, a recent study [16] reported a high prevalence
(92%) of sfbI among the persisting S. pyogenes strains
from the throats of patients with asymptomatic
carriage after antibiotic therapy. This observation
suggests that SfbI mediated internalization may be
responsible for persistence in that population. Indeed
using an in itro assay, an association between
persistent isolates and a high propensity to internalise
bacterial cells was demonstrated [17]. However, a
more recent German study [18] did not concur with
the above observation of a positive association
between sfbI-positive strains and persistence. In the
NT, sfbI is present in 60% of the S. pyogenes isolates
[19]. Furthermore, in contrast to Connecticut [20]
where throat is the primary site of infection for
invasive diseases, in the NT the primary site of
infection for group A streptococcus is the skin [4]. To
understand the differences in epidemiology and the
role of various FBPs, we have undertaken to screen
group A streptococcal strains cultured from blood of
patients with bacteraemia and necrotizing fasciitis,
and wound and throat swabs for the genetic en-
dowment of the four FBPs. Surprisingly, the results
show that endowment for SfbI, which is the only FBP
reported to mediate pathogen internalization of host
cells, is not associated with invasive diseases nor is it
overly represented in throat derived isolates. However,
a trend showing a greater proportion of prtFII-
positivity was observed among strains recovered from
the invasive disease cases.
MATERIALS AND METHODS
Strains : Group A streptococcus isolates from patients
across the tropical top end of the NT between 1990–8
were characterized by a molecular typing procedure,
called vir typing [21]. Vir typing is based on
polymerase chain reaction (PCR) and subsequent
restriction profiling of the mga locus, which comprises
genes for M and M-like proteins (emm), C5a peptidase
(scpA) and a regulator (mga). The isolates were from
(a) blood culture representing 35 bacteraemic and 2
necrotizing fasciitis cases (invasive diseases), and (b)
30 pyoderma and 8 throat infections. The details of
the site of isolation, vir types and other characteristics
are shown in Table 1. In all, 75 distinct vir types were
obtained from 73 subjects. One patient had bac-
teraemia episodes 11 months apart with 2 distinct vir
types (20.1 and 20.2) infecting, and another patient
had bacteraemia with vir type 5 isolated from blood
culture and 5 days later vir type 12.1 was isolated from
skin. In this study, vir types 20.1, 20.2 and 5 were
treated as strains from invasive disease cases and vir
type 12.1 was treated as a strain from uncomplicated
infection. In all, 37 vir types were from the invasive
diseases and the remaining 38 were from uncompli-
cated infections (Table 1). In this study Aborigines
account for 73% of the invasive disease cases.
DNA manipulations and Southern blots : Probes of
sfbI and prtFII were generated by PCR using the
following primer and template combinations: for
sfbI : 5-TATCAAAATCTTCTAAGTGCTGAG-3
and 5-AATGGAACACTAACTTCGGACGGG-3
with DNA template from JRS145; and for prtFII :
5-GAAGAAAAGCTTCCAGACGAGCAAGG-3
and 5-GGAATCTCAGAGTTACTTTCTGGTTC-
C-3 with DNA template from NS1140. Compo-
sition of PCR reaction mix was according to Hartas et
al. [21] and the cycling conditions were: 95 C for 15 s,
50 C (for sfbI ) or 60 C (for prtFII ) for 60 s, and
72 C for 60 s for 30 cycles. Genomic DNA from
group A streptococcus was prepared as described
by Chassy [22]. Briefly, cells from overnight cultures
(5 ml) were washed in 10 mm Tris, 1 mm EDTA (TE)
and resuspended in 300 μl TE. To this suspension,
700 μl of 24% polyethylene glycol 20000 in TE was
added. After treatment with lysozyme (20 mgml,
300 μl), lysates were prepared by the addition of
sodium dodecylsulphate (1% in TE) and incubation
at 65 C for 15 min. The lysates were treated with
RNase A (10 mgml) for 30 min and proteinase K
(20 mgml) for 30 min at 37 C. DNA was extracted
by phenolchloroform and precipitated by ethanol.
The DNA pellet was dissolved in TE for further
manipulations. The genomic DNA was digested with
SpeI and Southern blots hybridized with the radio-
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Table 1. Characteristics of NT study isolates
Isolate VT Date* IN† sfbI prtFII OF Site‡ Isolate VT Date* IN† sfbI prtFII OF Site‡
NS 730 22 24296 I    N NS 282 172 5395 N    W
NS 210 34 3694 I    B NS 836 46 12596 N    W
NS 931 57 13996 I    N NS 1033 322 14197 N    W
NS 192 32 12494 I    B NS 501 121 221091 N    W
NS 13 24 19291 I    B NS 179 72 22394 N    W
NS 101 331 111292 I    B NS 53 291 61191 N    W
NS 1140 101 27497 I    B NS 265 11 1395 N    W
NS 235 118 141194 I    B NS 351 22 20495 N    W
NS 1 23 16790 I    B NS 436 33 19695 N    W
NS 178 26 21394 I    B NS 32 292 21691 N    W
NS 43 9 15891 I    B NS 1096 32 24397 N    W
NS 882 174 29792 I    B NS 506 134 22895 N    W
NS 125 201 29693 I    B NS 1045 117 21197 N    W
NS 240 116 30195 I    B NS 564 119 21095 N    W
NS 225 115 131094 I    B NS 581 42 131095 N    W
NS 90 52 19892 I    B NS 611 37 191195 N    W
NS 223 4 30994 I    B NS 671 133 181295 N    W
NS 1133 171 29497 I    B NS 684 132 2196 N    W
NS 83 371 29692 I    B NS 803 131 13496 N    W
NS 50 5 171091 I    B NS 804 130 15496 N    W
NS 226 141 131094 I    B NS 980 129 121196 N    W
NS 8 25 1190 I    B NS 1030 77 10197 N    W
NS 80 69 23692 I    B NS 1095 128 25397 N    W
NS 344 127 15495 I    B NS 1099 126 1497 N    W
NS 476 39 17795 I    B NS 1122 65 22497 N    W
NS 6 122 1190 I    B NS 1185 135 7797 N    W
NS 20 34 7591 I    B NS 1210 125 17897 N    W
NS 25 18 12691 I    B NS 1216 491 10897 N    W
NS 66 412 17392 I    B NS 1353 44 7198 N    W
NS 195 120 19494 I    B NS 180 110 22394 N    T
NS 78 30 23692 I    B NS 182 60 24394 N    T
NS 204 121 18594 I    B NS 199 55 5594 N    T
NS 205 202 23594 I    B NS 236 111 161194 N    T
NS 216 122 14694 I    B NS 672 112 191295 N    T
NS 878 124 1696 I    B NS 678 113 231295 N    T
NS 909 123 20896 I    B NS 696 114 16196 N    T
NS 567 38 101095 I    B NS 1107 333 2497 N    T
NS 14 96 26191 N    W
* Collection date of isolates.
† I and N refer to classification of isolates from invasive and non-invasive cases respectively.
‡ Site or disease from which the organism was isolated: N, necrotizing fasciitis ; B, bacteraemia; W, wound skin; T, throat.
labelled probes to screen for sfbI and prtFII as
described earlier [19]. A similar approach to screen for
sfbII often gave ambiguous results as the hybridiza-
tion signals were weak, possibly due to sequence
variation in sfbII. Therefore, for this study the sfbII
status was inferred using opacity factor assays, which
correlates well with the genotype; in our earlier study,
24 of 25 sfbII positive strains are OF-positive [19].
Assay for opacity factor : This assay was performed as
described previously [23]. Briefly, overnight cultures
(5 ml) in Todd Hewitt broth containing 2% neopep-
tone were centrifuged and 10 μl of the supernatant
mixed with 100 μl horse serum in microtitre plate
wells. The plates were then incubated at 37 C
overnight in a humid chamber. One hundred micro-
litres of saline was mixed with the contents of each
well and then each well scored for opalescence.
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(underlined sequence contained restriction sites not
present in the fbp54 gene). PCR conditions employed
were as described above with an initial cycle of 94 C
for 2 min, 57 C for 2 min and 72 C for 2 min.
Amplification consisted for 35 cycles at 94 C for
1 min, 57 C for 1 min and 72 C for 15 min. The
reaction was completed with a final cycle of 94 C for
1 min, 57 C for 1 min and 72 C for 7 min.
RESULTS AND DISCUSSION
Our previous work showed that many commonly
circulating group A streptococcal strain in the
Northern Territory could cause invasive disease and
there is no one dominant strain [4]. Given this
observation, the demarcation between strains asso-
ciated with invasive and uncomplicated infections is
less defined. Nevertheless, it is possible that some
strains have greater predilection for invasion. Specific
virulence determinants that are required by strains to
cause invasive diseases are unknown. Given that
group A streptococcus may contain up to four genes
encoding FBP’s (sfbI, sfbII, prtFII and fbp54 ) and
that SfbI has been shown to be preferentially
associated with persistent cases of infection in one
study [16], the carriage of FBP genes by group A
streptococcus isolates from non-invasive and invasive
diseases was determined.
Since these S. pyogenes isolates belong to distinct
vir types, they are epidemiologically unrelated isolates.
Thirty-seven and 38 distinct vir types represented
isolates from invasive and the uncomplicated infec-
tions respectively. Overall they comprise about two
thirds of reported strains circulating in this region. All
isolates were positive for fbp54 without exception. For
OF, 38% of strains from invasive and 50% strains
from uncomplicated infections were positive (P
0288) suggesting that this protein may not have a role
in promoting invasive diseases. Since SfbI is sufficient
for GAS invasion of host cells, we anticipated that a
greater proportion of strains representing isolates
from invasive diseases might be positive for this gene
than those from uncomplicated infection. Contrary to
this expectation, we did not find a difference in the
distribution of sfbI between the two sets of strains (P
 07342). This result suggests that SfbI-mediated
internalization of host cells is not likely to be a
necessary characteristic of group A streptococcus for
invasive diseases. This interpretation is consistent
with the lack of sfbI among M types 1 and 18 that are
known to be associated with severe invasive diseases
elsewhere [24].
There are a few minor disconcordant observations
between this study and our earlier report [19]. Firstly,
unlike in the previous study, we found a few (7 strains)
OF-positive strains that are sfbI-negative. Nonethe-
less, a majority of OF-positive strains are sfbI-positive
(26 strains). Secondly, of the 32 vir types common to
both the studies, 7 strains showed different distribu-
tions for sfbI and sfbIIOF. Reasons for this could be
due to different isolates representing the same vir
types used in these studies. Despite these minor
differences, there is overall agreement in the sfbI and
OF distribution in both the studies.
Forty-five of the 75 NT strains (60%) possess
prtFII. A larger proportion (70%) is represented
among the strains from the blood than among the
strains from uncomplicated infections (50%) (P
0073). Although this is not statistically significant, the
trend is important given high endemicity of group A
streptococcus infection in this area (‘passenger ’ strain
hypothesis, see below).
S. pyogenes may utilize different adhesins for
attachment and colonization of different tissues and
for invasion. For instance, M protein may mediate
adherence to keratinocytes in the epidermis, whereas
SfbI may be necessary for adherence of group A
streptococcus to pharyngeal cells and Langerhans’
cells, a component of the basal layer of the epidermis
[25]. Different repertoires of adhesins and their
regulators, and the interactions of the adhesins with
each other may determine tissue tropism and patho-
genicity of S. pyogenes. In Table 1, 21% of the strains
from uncomplicated infections are from the throat.
Comparison of the distribution of the FBP genes
between these throat isolates and the woundskin
isolates revealed no significant difference (P 1000
for sfbI ; P 0232 for OF; P 0698 for prtFII ).
Calculations on the permutations of association of
OF, sfbI and prtFII were also investigated but did not
reveal any significant result. These observations
suggest that the primary site of infection cannot be
attributed to any of the four FBPs.
Several reports describe that a limited number of
clones are responsible for group A streptococcal
invasive diseases [26–29]. These studies were carried
out in non-endemic regions for streptococcal infection
where the per capita diversity of the organism is likely
to be low. Our recent studies with isolates from the
tropical NT where the per capita diversity of group A
streptococcus is high [2] reveal that many strains may
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cause invasive disease and that there is no clonal
spread of a dominant strain among both Aboriginal
and non-Aboriginal residents. This raises questions
regarding the identity of common features of the
group A streptococcal strains, which render them
more invasive. While prtFII is present in a greater
proportion of invasive vir types, 30% of the vir types
that were isolated from the invasive disease patients
did not harbour the gene. This suggests that factors
other than PrtFII, such as NAD glycohydrolase [30],
may also increase the invasive propensity of group A
streptococcus. Alternatively, in a population with a
high pathogen load where infection with multiple
types is common and where multiple types have been
recovered from an impetigo lesion [31], a co-infecting
prtFII-positive strain might somehow promote a less
benign prtFII-negative ‘passenger ’ strain to cause
invasive disease.
Our finding, that the strains with genetic endow-
ment of prtFII are more likely to be recovered from
invasive disease cases than strains that lack the gene,
has implications for an FBP-based vaccine. The
knowledge of distribution of FBP genes among S.
pyogenes isolates from defined geographical areas
may provide a basis for selection of appropriate
antigens. Finally, despite inference of an association
between SfbI-mediated cellular uptake and persistent
infection, our data failed to show greater distribution
of sfbI among strains from invasive disease cases.
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